CDKN1A and metabolic dysfunction-associated steatotic liver disease: NAFLD patients have been reported to show shortened telomere length and increased expression of markers of cell cycle arrest/DNA damage, including p53, 53BPI, p21 and γH2AX [35, 56–58].